A public limited company listed at Bombay Stock Exchange and National Stock Exchange of India Limited achieved a turnover of INR10691.90 Million for year ended March 31, 2010. Ankur is extensively engaged in the manufacturing of pharmaceutical formulation since 1997, having multi location manufacturing units located at Daman [Union Territory] and Baddi [Himachal Pradesh]. The Company's major expansion program with a view to cater to the international market has been validated for commissioning.
Ankur has to its credit several distinctions. It's in the forefront of contract manufacturing with India's leading and multinational pharmaceutical companies. Ankur's first plant is situated at Daman, which is having dedicated block for General and Betalactum products in oral dosage form.
The Company has set-up two plants spread across "dimensions" at Himachal Pradesh in excise and pollution free zone, amongst lush green surroundings. The main object behind setting up two units was to cater Domestic and International Market.
Our more than 400 different formulations of various dosage forms i.e. Tablets, Capsules, Dry Syrups, Liquid Orals, Injectables, Oinments, etc. are currently manufactured in Ankur's multi location manufacturing facilities. Company has already received WHO GMP Certification for both Units at Himachal Pradesh.